Authors


Lindsey Boody, OD

Latest:

Autism spectrum disorder in children requires patience, flexibility

How to tailor an eye examination and what technology to consider.


Dr. Scott Edmonds, chief eye care officer, UnitedHealthcare

Latest:

5 tips to help block blue light in an increasingly remote world

As consistent use of digital devices remains a fact of life for people of virtually all ages, consider this expert advice


Thomas E. Sullivan, MD

Latest:

Improve medication adherence with technology

Technology can facilitate secure communication between physician and patient


Christopher S. Wolfe, OD, FAAO, Dipl ABO

Latest:

Visualizing periphery is part of a comprehensive eye exam

When preventing disease, optometrists should not give away any care



Rebecca Alexander, LCSW-R, MPH

Latest:

Vision loss's role in accessibility advocacy with Rebecca Alexander

Rebecca Alexander, LCSW-R, MPH, has been gradually losing both her vision and hearing since she was a teenager due to Usher syndrome type 3. She discusses the importance of making practice accessible for those with vision loss in an exclusive interview.


Kristen Ingenito, MBA

Latest:

G360 2023: A bird’s eye view of innovation

Kristen Ingenito, MBA, gives key takeaways from her G360 presentation, "A bird’s eye view of innovation."


Jason E. Vice, PhD, OT, SCLV

Latest:

A new era of assistive technology for patients with low vision

OrCam devices incorporate cutting-edge AI advancements that empower patients to live more independent lives.


James Deom, OD, MPH, FAAO, FSLS

Latest:

ODs can fill need for postconcussion vision rehab

Educate providers, build a referral network, and add tools of the trade


Denise Whittam, OD

Latest:

Tackling the problem of contact lens dropout from presbyopia

With advanced, easy-to-fit multifocal lens technologies, patients don’t need to compromise



Langis Michaud, OD, MSc, FAAO, FSLS, FBCLA, FEAOO

Latest:

Dr. Michaud's #1 tip for managing dry eye

Langis Michaud, OD, MSc, FAAO, FSLS, FBCLA, FEAOO, shares his number 1 tip for managing dry eye.


Ruth Shoge, OD, MPH, FAAO

Latest:

Diversity, equity, inclusion, and belonging—in practice

As efforts continue across the globe, optometrists need to take action in clinics.


Phillip T. Yuhas, OD, PhD, FAAO

Latest:

AAOpt 2022: The emerging role of biomechanics in glaucoma

Phillip T. Yuhas, OD, PhD, FAAO, discusses key takeaways from his presentation, "Stress management: the emerging role of ocular biomechanics in glaucoma," which he presented during the 2022 AAOpt.


Brandon Grama

Latest:

New topical therapies for dry eye disease

Nasal spray may fill the gaps left by artificial tears.


Srinivas Kondapalli, MD

Latest:

Vision Expo East 2024: Live Rinsada demonstration

At Vision Expo East 2024, Srinivas Kondapalli, MD, demonstrates how to use Rinsada to address ocular surface disease.


Karen Walsh, BSc(Hons) PGDip MCOptom FIACLE

Latest:

Moving beyond refractive error correction

Prepare for the future of contact lenses with innovations on the horizon


Leela V. Raju, MD

Latest:

Faster epithelial healing for patients with corneal abrasion and PRK

Shifting the treatment paradigm can lead to less pain, inflammation


Peg Achenbach, OD, FAAO

Latest:

G360 2024: Rehashing glaucoma treatments with Dr Michael Chaglasian

Optometry Times chats with Michael Chaglasian, OD, FAAO during this year's Glaucoma 360 meeting in San Francisco, California.


Bryan Wilson, PhD, MBA

Latest:

Deciding on Birmingham as site of ADA, Genentech's diabetic eye disease manuscript

Bryan Wilson, executive director of medical affairs at Genentech, details why Birmingham, Alabama was chosen as the community to study the effects of diabetic eye disease among African Americans in a new manuscript from the ADA and Genentech.


Ethan Wohlgemuth, OD

Latest:

A retrospective case analysis of high-risk biomarkers for geographic atrophy development and multimodal imaging features of early GA

Early detection of incipient geographic atrophy is critical to identify patients at greatest risk of progression and who may benefit most from newly approved complement inhibition therapies.


Salvador Gonzalez Jr, OD

Latest:

Current glaucoma treatments bring challenges

Optometrists must identify and mitigate complications for this patient base.


Melissa Levine, OD

Latest:

Higher-order aberration correction with scleral lenses

When considering the best modality these lenses' stability are superior.


Cathleen McCabe
Cathleen M. McCabe, MD

Latest:

Meeting the need: Screening parameters for presbyopia-correcting drops

Doctors should consider a few key points before writing a prescription.


Sherrol A. Reynolds, OD, FAAO

Latest:

AAOpt 2022: The latest updates on common autoimmune diseases

Sherrol Reynolds, OD, gives key takeaways from her co-presentation on the most common autoimmune diseases and their latest updates, which she discussed at AAOpt 2022.


Brittany Warner, OD

Latest:

Differential key to diagnosing idiopathic orbital inflammation

Orbital cellulitis, orbital mass, and potential other conditions could mask diagnosis


Jennifer S. Harthan, OD, FAAO, FSLS

Latest:

Drops vs inserts: Which increases adherence?

For patients with keratoconus-related inflammation, an intracanalicular steroid insert rivals the effectiveness of eye drops while boosting adherence.


Robert Fintelmann, MD, FACS

Latest:

Monitor keratoconus progression after cross-linking treatment

Successful outcomes demand both corneal and contact lens expertise.


Michele Andrews, OD

Latest:

The Myopia Collective: AOA, CooperVision unveil exciting new collaboration

Michele Andrews, OD, vice president of professional and government affairs for CooperVision, and Terri A. Gossard, OD, MS, member of the AOA board of trustees, sat down with Optometry Times to discuss the goals and tactics of The Myopia Collective.


Graham Erickson, OD, FAAO, FCOVD

Latest:

AAOpt 2023: Understanding nystagmus and providing better patient care

Nystagmus can be an intimidating condition, but understanding the treatment options can help patients feel as if they have more control.

© 2024 MJH Life Sciences

All rights reserved.